Form 4/A for DCOY Decoy Therapeutics Inc.
Accepted 2022-06-06 00:00:00 ET · period of report 2019-11-25 · accession 0001615219-22-000089 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AI | 2022-06-06 | 2019-11-25 | DCOY | HANISH ARNOLD C | Dir | P - Purchase | $3.59 | +3,000 | 3,000 | New | +$10.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2019-11-25 | P | A | 3,000 | $3.59 | 3,000 | I By Arnold C. Hanish Trust | — | — | (F1) This Form 4/A is being filed to amend the Form 4 filed by the Reporting Person on November 26, 2019 to reflect that the securities reported are indirectly beneficially owned as indicated herein. |